| Product Code: ETC8282587 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Major Depressive Disorder Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Major Depressive Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Major Depressive Disorder Market - Industry Life Cycle |
3.4 Mexico Major Depressive Disorder Market - Porter's Five Forces |
3.5 Mexico Major Depressive Disorder Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Mexico Major Depressive Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health issues in Mexico |
4.2.2 Growing prevalence of major depressive disorder in the Mexican population |
4.2.3 Rising disposable income leading to higher healthcare spending for mental health treatments |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders in Mexican society |
4.3.2 Limited access to mental health services and specialists in certain regions of Mexico |
4.3.3 High cost of prescription medications and therapy sessions for major depressive disorder patients |
5 Mexico Major Depressive Disorder Market Trends |
6 Mexico Major Depressive Disorder Market, By Types |
6.1 Mexico Major Depressive Disorder Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Mexico Major Depressive Disorder Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Mexico Major Depressive Disorder Market Revenues & Volume, By Auvelity (Bupropion/dextromethorphan), 2021- 2031F |
6.1.4 Mexico Major Depressive Disorder Market Revenues & Volume, By Lexapro (Escitalopram), 2021- 2031F |
6.1.5 Mexico Major Depressive Disorder Market Revenues & Volume, By Paxil (Paroxetine), 2021- 2031F |
6.1.6 Mexico Major Depressive Disorder Market Revenues & Volume, By Zoloft (Sertraline), 2021- 2031F |
6.1.7 Mexico Major Depressive Disorder Market Revenues & Volume, By Viibryd (Vilazodone), 2021- 2031F |
6.1.8 Mexico Major Depressive Disorder Market Revenues & Volume, By SEP-363856, 2021- 2031F |
6.1.9 Mexico Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
6.1.10 Mexico Major Depressive Disorder Market Revenues & Volume, By REL-1017, 2021- 2031F |
7 Mexico Major Depressive Disorder Market Import-Export Trade Statistics |
7.1 Mexico Major Depressive Disorder Market Export to Major Countries |
7.2 Mexico Major Depressive Disorder Market Imports from Major Countries |
8 Mexico Major Depressive Disorder Market Key Performance Indicators |
8.1 Number of mental health awareness campaigns conducted annually |
8.2 Percentage increase in the diagnosis rate of major depressive disorder in Mexico |
8.3 Average waiting time for patients seeking mental health treatment in Mexico |
9 Mexico Major Depressive Disorder Market - Opportunity Assessment |
9.1 Mexico Major Depressive Disorder Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Mexico Major Depressive Disorder Market - Competitive Landscape |
10.1 Mexico Major Depressive Disorder Market Revenue Share, By Companies, 2024 |
10.2 Mexico Major Depressive Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here